Precirix
Last board
1 director, 1 auditor, no change since January 2026Pharmetis Sàrl
Director, permanent representative Plitz Thomas
director appointed by deed of 20-03-2024
director appointed by deed of 13-11-2024
Statutory auditor, permanent representative Bert Kegels
current term since 08-05-2024
term until 14-05-2027
listed in the 2025 annual accounts, filed on 12-05-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Externe vertegenwoordigingsmacht De Vennootschap wordt in al haar handelingen, met inbegrip van de vertegenwoordiging in rechte…”deed of 03-03-2022
Permanent representatives 2
Mandates through the years
29 names, the dashed line is todayBDO
Statutory auditor
Statutory auditor
Pharmetis Sàrl
Director
Director
QUINZ
Liquidator
Liquidator
BOS Jasper Marnix
Director
Director
Burkov Ivan
Director
Director
Cetium AS
Non-executive director
Non-executive director
Hansen Camilla Petrycer
Director
Director
Mesonax Ltd
Independent director
Independent director
Steen Marten
Director
Director
Vlemmix Michaël
Director
Director
Sabine Dandiguian
Board director
Board director
Hasseltberg
Director
Director
BOTTI Simone
Director
Director
HAMMER Ohad
Director
Director
TAKKE Christina
Director
Director
Karl Nägler
Director
Director
DØSSING Morten Graugaard
Director
Director
Jacobus BOONEN
Director
Director
RAES Geert Mark
Director
Director
Tony Lahoutte
Director
Director
WILLEMSE Jan Justine Henri
Director
Director
GROWTH FACTOR
Managing director and chair of the board
Managing director and chair of the board
DE VOS Jens
Director
Director
DEVOOGDT Nick Mark
Director
Director
Other functionEarliermandate already running before its first mentionend not dated
Mandates as a list
- BDO
- Statutory auditor, appointed by deed of 04-12-2018, still in office
- Pharmetis Sàrl
- Director, from before 31-12-2023 to 20-01-2026
- Director, appointed by deed of 13-11-2024, still in office
- QUINZ
- Liquidator, since before 17-12-2025
- BOS Jasper Marnix
- Director, from before 31-12-2021 to 20-01-2026
- Burkov Ivan
- Director, appointed by deed of 13-11-2024, until 20-01-2026
- Cetium AS
- Non-executive director, appointed by deed of 24-04-2019, until 20-01-2026
- Hansen Camilla Petrycer
- Director, appointed by deed of 13-11-2024, until 20-01-2026
- Mesonax Ltd
- Independent director, from 12-10-2022 to 20-01-2026
- Steen Marten
- Director, appointed by deed of 04-12-2018, until 20-01-2026
- Vlemmix Michaël
- Director, appointed by deed of 04-02-2020, until 20-01-2026
- Sabine Dandiguian
- Board director, until 06-03-2025
- Hasseltberg
- Day-to-day manager, appointed by deed of 18-01-2018, ended, last mentioned on 18-01-2018
- Director, appointed by deed of 30-11-2017, until 14-11-2018
- Director, appointed by deed of 04-12-2018, until 20-03-2024
- Director, appointed by deed of 04-12-2018, last mentioned in 2018
- BAUDHUIN Jean Louis Marie Clément
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- Director, appointed by deed of 04-12-2018, until 03-03-2022
- BOTTI Simone
- Director, from before 31-12-2021, no longer listed in the 2025 annual accounts
- HAMMER Ohad
- Director, appointed by deed of 04-12-2018, until 03-03-2022
- MOUMDJIAN (geh. DANDIGUIAN) Sabine Kohar
- Director, from before 31-12-2021, no longer listed in the 2025 annual accounts
- TAKKE Christina
- Director, appointed by deed of 04-12-2018, until 03-03-2022
- Karl Nägler
- Director, appointed by deed of 04-12-2018, until 16-10-2019
- DØSSING Morten Graugaard
- Director, appointed by deed of 04-12-2018, no longer listed in the 2025 annual accounts
- DE LEENER Pierre Marie Edgard Joseph Ghislain
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- Jacobus BOONEN
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- Chair of the board, appointed by deed of 29-07-2015, ended, last mentioned on 29-07-2015
- MAJOIE Jérome Jean-Ghislain Hugues
- Director, appointed by deed of 16-06-2017, until 14-11-2018
- RAES Geert Mark
- Director, appointed by deed of 24-10-2014, until 09-07-2015
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- Tony Lahoutte
- Director, appointed by deed of 24-10-2014, until 09-07-2015
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- WILLEMSE Jan Justine Henri
- Director, appointed by deed of 29-07-2015, until 14-11-2018
- Managing director, appointed by deed of 29-06-2016, ended, last mentioned on 29-06-2016
- GROWTH FACTOR
- Director, appointed by deed of 24-10-2014, until 09-07-2015
- Managing director and chair of the board, appointed by deed of 24-10-2014, last mentioned in 2014
- Managing director and chair of the board, appointed by deed of 24-10-2014, until 17-06-2016
- Managing director and chair of the board, appointed by deed of 24-10-2014, last mentioned in 2014
- D'HUYVETTER Matthias Bruno Líeven
- Director, appointed by deed of 24-10-2014, until 09-07-2015
- DE VOS Jens
- Director, appointed by deed of 24-10-2014, until 09-07-2015
- DEVOOGDT Nick Mark
- Director, appointed by deed of 24-10-2014, until 09-07-2015
Control
Shareholder
Equity €26,465
Loss €3.0m in 2025 (loss €19,036 in 2024)
3.45%
This company
Precirix
Equity -€15.7m
Loss €15.7m in 2025
Capital
- Capital
- €21,529,954.30
- Shares
- 293,607
- Contribution per share
- €73.33
- Equity per share
- -€53.35 in 2025
- Source
- deed of 20-01-2026
Owners through the years
as the annual accounts name themOwners as a list
- V-Bio Co-Invest 1-1
- V-Bio Fund 1
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 07-03-2024 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsAt most 10 directorsTerm of at most 6 yearsdeed of 07-03-2024 (in Dutch)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “12.5.2 toelating erfgenamen-legatarissen bij overlijden en afkoop bij weigering, alle aandeelhouders andere dan…”“12.6.1 volledig Volgrecht, een of meer kandidaat-overdrager(s) rechtstreeks/onrechtstreeks alleen/in overleg met derden in een of meerdere…”“12.6.2 kennisgeving Volgrecht, aangetekend schrijven”“12.6.2 uitoefening Volgrecht, aangetekend schrijven (Kennisgeving van Uitoefening)”“12.6.2 gevolgen uitoefening en niet-uitoefening Volgrecht, bij verzaking of geen standpunt binnen periode vrij overdragen/verkopen aan Derde…”“12.7 Volgplicht, kandidaat-overdragers kunnen andere aandeelhouders verplichten over te dragen aan kandidaat-koper”deed of 29-07-2015 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of May at 16:00deed of 20-01-2026 (in Dutch)
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Artikelen 2:87 e.v. tenzij AV bij gewone meerderheid anders met rechten stemrechtloze Kapitaalaandelen, bestuurders in functie tenzij AV…”deed of 20-01-2026 (in Dutch)
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 30-11-2017 ↗
- BAUDHUIN Jean Louis 1,134 shares · €112,929.46
- WILLEMSE Jan 1,134 shares · €112,929.46
- DE LEENER Pierre Marie 1,134 shares · €112,929.46
- FONDATION FOURNIER MAJOIE POUR L'INNOVATION (BE 0886.551.096) 568 shares · €56,564.32
- DEVENYNS Ruth Martine Yvonne 1,030 shares · €102,572.61
After 4 capital increases
deed of 29-07-2015 ↗
- WILLEMSE Jan Justine Henri 1,004 shares · “kapitaalaandelen van categorie B”
- BAUDHUIN Jean Louis Marie Clément 1,004 shares · “kapitaalaandelen van categorie B”
- ADRINEKA (BE 0885.357.008) 1,004 shares · “kapitaalaandelen van categorie B”
- FONDATION FOURNIER MAJOIE POUR L'INNOVATION (BE 0886.551.096) 502 shares · “kapitaalaandelen van categorie B”
Capital over time
- 20-01-2026 Capital stated in 2 deeds · €21,529,954.30 · 293,607 shares
- 03-03-2022 Capital increase of €9,777,308.89 · to €21,529,954.30 · 133,333 new shares at €300 per share · in cash
- 02-10-2020 Capital stated in the deed · €11,752,645.41 · 160,274 shares
- 16-07-2020 Capital increase of €4,705,219.45 · to €11,752,645.41 · 64,165 new shares, 40% of the 160,274 shares after the increase
- 04-12-2018 Capital increase of €4,033,150 · to €7,047,425.96 · 55,000 new shares at €200 per share, 57.2% of the 96,109 shares after the increase
- 30-11-2017 Capital increase of €497,925.31 · to €3,014,275.96
- 16-06-2017 Capital increase of €995,850.65 · to €2,516,350.65 · in cash
- 29-07-2015 Capital increase of €350,000 · to €470,500 · 3,514 new shares · in cash
Show 5 older capital entries
- 29-07-2015 Capital increase of €350,000 · to €470,500 · 3,514 new shares
- 29-07-2015 Capital increase of €1,050,000 · to €1,520,500 · 10,545 new shares · in cash
- 29-07-2015 Capital increase of €1,050,000 · to €1,520,500
- 10-06-2015 Capital increase of €59,000 · to €120,500 · 5,900 new shares, 49% of the 12,050 shares after the increase
- 24-10-2014 Incorporation · €61,500 · 6,150 shares